Latest Lead News

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

Mayur Resources has locked in $11.2 million in funding from Pacific Unison to kickstart production at its Orokolo Bay Industrial Sands Project in Papua New Guinea, targeting 500,000 tonnes of magnetite annually by late 2025.

Generation Development Group (GDG) has announced a $320 million acquisition of Evidentia Group Holdings, funded by a $287.9 million equity raising. The deal positions GDG as a market leader in the rapidly expanding Managed Accounts sector with expected earnings accretion in FY26.

Nanoveu Limited has completed the strategic acquisition of Embedded A.I. Systems Pte. Ltd. (EMASS), positioning itself at the forefront of ultra-low-power AI-driven edge semiconductor solutions. This move aims to enhance its EyeFly3D™ platform and expand into rapidly growing markets such as wearables, IoT, and autonomous devices.

Dexus Convenience Retail REIT (ASX: DXC) reported steady half-year results for 2025, underpinned by active portfolio management and ongoing redevelopment projects. The fund remains on track to meet full-year guidance while enhancing income security and growth potential.

Keybridge Capital Limited has appointed a voluntary administrator following a series of legal setbacks and an inability to raise crucial capital, leading to the suspension of its shares.

BlinkLab has secured North Shore Pediatric Therapy as the second US clinical site in its autism diagnostic study, enhancing recruitment and data quality with a leading Chicago-based specialist.

PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.

Radiopharm Theranostics' RAD 101 radiotracer demonstrates high sensitivity in detecting brain metastases using a novel PET-mpMRI approach, with a Phase 2b trial now recruiting in the US.

Coolabah Metals Limited is undertaking a $3-4 million capital raise to fund the acquisition of Broken Hill Mines Pty Ltd and its subsidiary, aiming to re-list on the ASX and focus on developing the Rasp and Pinnacles Mines.

MyEco Group Ltd is advancing its transformation into a global leader in sustainable packaging, refining its sales and production strategies to drive growth and achieve positive EBITDA.